By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Syndax Pharmaceuticals Inc. 

400 Totten Pond Road
Suite 110
Waltham  Massachusetts  02451  U.S.A.
Phone: 781-419-1400 Fax: 781-419-1420


SEARCH JOBS



Segment
Start Up





Company News
Syndax Announces Expansion Of Immuno-Oncology Collaboration Evaluating Entinostat In Combination With KEYTRUDA (Pembrolizumab) For The Treatment Of Colorectal Cancer 4/27/2017 11:20:01 AM
Syndax Adds Biopharmaceutical Industry Leader Keith A. Katkin To Board Of Directors 4/4/2017 12:06:08 PM
Syndax To Announce Fourth Quarter And Year-End 2016 Financial Results And Host Conference Call And Webcast On March 2, 2017 2/16/2017 8:17:20 AM
Syndax Appoints Richard P. Shea As Chief Financial Officer 2/9/2017 8:17:54 AM
Syndax Appoints Lisa M. Coussens, Ph.D., To Scientific Advisory Board 1/31/2017 7:39:31 AM
Syndax Announces Collaboration With The NCI To Develop Entinostat And SNDX-6352 For The Treatment Of Cancer 12/14/2016 7:12:31 AM
Syndax Reports Third Quarter 2016 Financial Results And Provides Business Update 11/11/2016 11:12:08 AM
Syndax To Announce Third Quarter 2016 Financial Results And Host Conference Call And Webcast On November 10, 2016 10/28/2016 8:00:42 AM
Syndax Reports Second Quarter 2016 Financial Results And Provides Business Update 8/9/2016 10:57:38 AM
Syndax Appoints Leading Experts To Scientific Advisory Board (SAB) 7/27/2016 8:44:25 AM
12345678
//-->